Fundz

Co-Diagnostics, Inc. Appoints Richard Abbott as President and Announces Key Executive Appointments

PUBLIC · CODXApr 04, 2024

Position

Chief Operations Officer

Company

Co-Diagnostics, Inc.

David Nielsen
d.nielsen@co-dx.com
Salt Lake CityManufacturingBiotechnologyHealth CareScience And EngineeringHealth Diagnostics

Description

Co-Diagnostics, Inc. announced the appointment of Richard Abbott as President, and the naming of David Nielsen as Chief Operations Officer (COO), Christopher Thurston as Chief Technology Officer (CTO), and Seth Egan as Chief Commercialization Officer (CCO). The company aims to leverage the background and experience of these accomplished individuals as crucial additions to the management team for the next stage of growth, with a focus on addressing the decentralized approach to diagnostics and filling the equitable diagnostics access gap.

Quick answer

Co-Diagnostics, Inc. Appoints Richard Abbott as President and Announces Key Executive Appointments (April 4, 2024). Co-Diagnostics, Inc. is based in Salt Lake City, Utah, United States.

What did Co-Diagnostics, Inc. announce on April 4, 2024?
Co-Diagnostics, Inc. announced the appointment of Richard Abbott as President, and the naming of David Nielsen as Chief Operations Officer (COO), Christopher Thurston as Chief Technology Officer (CTO), and Seth Egan as Chief Commercialization Officer (CCO). The company aims to leverage the background and experience of these accomplished individuals as crucial additions to the management team for the next stage of...
What does Co-Diagnostics, Inc. do?
At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to...
Where is Co-Diagnostics, Inc. based?
Co-Diagnostics, Inc. is based in Salt Lake City, Utah, United States.
Which similar companies made leadership changes around the same time?
Exact Sciences (April 15, 2024), Amarna Therapeutics (April 19, 2024), Electra Therapeutics (May 1, 2024) and QuidelOrtho (May 2, 2024) also announced leadership changes within 45 days of Co-Diagnostics, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Science And Engineering and Health Diagnostics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Co-Diagnostics, Inc., and when

A new leader at Co-Diagnostics, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Co-Diagnostics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Co-Diagnostics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Co-Diagnostics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Co-Diagnostics, Inc.

Location

2401 South Foothill Drive

Salt Lake City, Utah, United States

About

At Co-Diagnostics, we are passionate about providing the most robust and innovative molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications, especially to those regions where pricing is paramount. Our proprietary molecular diagnostics technology is paving the way for innovation in disease detection and life sciences research through our enhanced detection of genetic material. Because we own our platform, we are able to accomplish this faster and more economically, allowing for wider margins while still positioning Co-Diagnostics to be the worldwide low-cost leader of molecular diagnostics services.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Co-Diagnostics, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ivory
Likely contact at this company
••••••••@••••••••

See Ivory's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Co-Diagnostics, Inc.'s next move

Learn about Strategic plan

Co-Diagnostics, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.